Risk Factors of Jaw Osteoradionecrosis in Oral Cavity Cancer Patients Post-Radiotherapy (AOITC)
Risk Factors of Jaw Osteoradionecrosis in Oral Cavity Cancer Patients Post-Radiotherapy: A Multi-center Retrospective Cohort Study
Osteoradionecrosis (ORN) of the jaw is a serious complication that can occur after radiation therapy for head and neck cancers, including oral cavity cancer (OCC). ORN happens when jawbone tissue dies and fails to heal, often triggered by dental issues like tooth extractions or poorly fitting dentures. Symptoms can include exposed bone, pain, difficulty opening the mouth, trouble swallowing, and even jaw fractures-leading to major physical and emotional challenges.
The likelihood of ORN varies widely, from less than 1% to over 50% in head and neck cancer patients. For OCC specifically, studies report rates from 4% up to 25%. Treatment depends on how much bone is affected and can range from medication to major surgery.
Risk factors include radiation dose, tumor location, oral health, dental extractions, lifestyle habits (like alcohol use), and other health conditions. Poor oral hygiene, high radiation doses, and alcohol use are among the most common risks. However, current data on OCC patients is limited and often not broadly applicable.
This study will retrospectively examine what increases the risk of ORN in OCC patients who received radiation therapy before or after surgery. Using data from multiple international centers, it aims to identify patterns and provide globally relevant insights. The results will help guide prevention strategies and create evidence-based guidelines to reduce ORN and improve long-term outcomes for these patients.
Przegląd badań
Status
Status
Warunki
Warunki
Typ studiów
Typ studiów
Zapisy (Szacowany)
Zapisy
Kontakty i lokalizacje
Kontakt w sprawie studiów
Kontakt w sprawie studiów
- Nazwa: Benjamin Bretzinger
- Numer telefonu: +41 81 414 21 11
- E-mail: benjamin.bretzinger@aofoundation.org
Kryteria uczestnictwa
Kryteria kwalifikacji
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Patients will be selected from the primary care center where the patients received their initial treatment and followed up for at least 24months
Opis
Inclusion Criteria:
- Adults (≥18 years) diagnosed with OCC and treated with radiotherapy with curative intent (preoperative or/and postoperative, not palliative; definitive RT)
- Patients who completed the full prescribed radiotherapy course; patients remain eligible if radiotherapy was discontinued due to suspected and subsequently confirmed ORN
- Available, complete medical records including RT details, oral status, comorbidities, dental procedure details (as applicable), and lifestyle factors (as applicable)
- Documented informed consent from the treated patient, where applicable, permitting the use of their medical records for research purposes, in accordance with the requirements of the Institutional Review Board (IRB) or Ethics Committee (EC).
- Availability of at least 24 months of follow-up data after completion of radiotherapy, or follow-up until the occurrence of ORN, death, or loss to follow-up, whichever occurs first.
- Completion of the radiotherapy course on or before 31 December 2024.
Exclusion Criteria:
- Patients with non-oral cavity primary cancers (eg, oropharynx, larynx)
- Patients treated only with surgery or conservatively, without any form of RT
- Incomplete or missing medical records
- Record of use of antiresorptive (eg, bisphosphonate, denosumab) and antiangiogenic drugs
- Patients with jaw necrosis attributable to non-radiation-related causes, such as medication-related osteonecrosis of the jaw (MRONJ), trauma, or odontogenic infections
- Patients with known metastatic bone disease in the jaw
- Patients who discontinued radiotherapy for reasons unrelated to ORN suspicion or confirmation (eg, death, dropout, treatment intolerance, or other non-ORN related causes)
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Modele obserwacyjne: COHORT
- Perspektywy czasowe: RETROSPECTIVE
Liczba grup / kohort
Kohorty i interwencje
Grupa / KohortaGrupa / Kohorta |
|---|
|
Cases (ORN group)
Developed clinically and radiographically or histologically confirmed osteoradionecrosis (ORN) of the jaw following radiotherapy. |
|
Control (non-ORN group)
No clinical, radiological, or histological diagnosis of ORN during the follow-up period. |
Co mierzy badanie?
Podstawowe miary wyniku
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Development of osteoradionecrosis (ORN) of the jaw
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
The primary outcome is the development occurrence (yes/no) of ORN after completion of pre- and/or postoperative RT. The objective is to identify and evaluate patient-, tumor-, treatment-, and region-related risk factors associated with the development of ORN across multiple geographic regions. Scoring Scale: The primary endpoint will be treated as a binary variable: 0 = No ORN 1 = Development of ORN Time to ORN onset (interval between completion of RT and clinical diagnosis of ORN) will also be recorded for time-to-event analyses. |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
Miary wyników drugorzędnych
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Incidence of ORN Across Geographic Regions
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To compare the incidence rates across geographical regions, namely between the Eastern and Western world, and High-Income Countries versus Low and Middle-Income Countries. |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Severity of ORN by Tumor Characteristic
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To evaluate the variability in the severity of osteoradionecrosis (ORN) based on primary tumor site (eg, tongue, floor of mouth, oral tongue, buccal mucosa, gingiva), histological tumor type (eg, adenoid cystic carcinoma, squamous cell carcinoma), and tumor characteristics including size, clinical stage (T1-T4), overall stage (III-IVA), and nodal status (N0, N1-2B, N2C, N3 |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Association between radiotherapy dose and ORN severity
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To investigate the association between radiotherapy dose parameters (total dose and duration) and the severity grade of ORN among patients who develop ORN. Is there a correlation between increased radiation dose and duration and the severity of the condition? |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Incidence and severity comparison of preop vs. postop RT
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To compare the incidence and severity of ORN in patients undergoing preoperative versus postoperative radiotherapy |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Incidence comparison across RT modalities
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To compare the incidence ORN across different radiation modalities, including intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), and conventional three-dimensional conformal radiotherapy (3D-CRT) |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
To determine whether the mandible is more susceptible to ORN than the maxilla, or vice versa.
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To determine whether the mandible is more susceptible to ORN than the maxilla, or vice versa. |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
Complication evaluation with pre- or postop RT
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To evaluate potential complications associated with preoperative and postoperative radiotherapy |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
To analyze the influence of pre-radiotherapy dental extractions and oral hygiene status on the risk of developing ORN
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To analyze the influence of pre-radiotherapy dental extractions and oral hygiene status on the risk of developing ORN |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
|
To examine the variability in ORN incidence and severity between patients who undergo dental extractions before versus after the completion of RT
Ramy czasowe: After completion of pre-and/or postoperative radiotherapy up to 24 months
|
To examine the variability in ORN incidence and severity between patients who undergo dental extractions before versus after the completion of RT |
After completion of pre-and/or postoperative radiotherapy up to 24 months
|
Współpracownicy i badacze
Sponsor
Sponsor
Śledczy
Śledczy
- Główny śledczy: Khalid Abdel-Galil, MD, Hamad Medical Corporation PO Box 3050 Doha, Qatar
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Szacowany)
Rozpoczęcie studiów
Zakończenie podstawowe (Szacowany)
Zakończenie podstawowe
Ukończenie studiów (Szacowany)
Ukończenie studiów
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Pierwszy wysłany
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia wysłana aktualizacja
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
Inne numery identyfikacyjne badania
- ORN of the Jaw
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .